Literature DB >> 26538129

Automated implantable cardioverter defibrillator lead infection in a patient with previous superior vena cava thrombosis.

Tara Connelly1, Sadiq Siddiqui2, Walenty Kolcow2, Dave Veerasingam2.   

Abstract

We present a case of a 44-year-old woman who presented with cough, pleuritic chest pain and fever leading to a diagnosis of pneumonia±pulmonary embolism. She had a history of familial hypertrophic obstructive cardiomyopathy (HOCM), for which an automated implantable cardioverter defibrillator (AICD) had been implanted, and a subsequent superior vena cava (SVC) thrombus, for which she was anticoagulated with warfarin. On admission, blood cultures grew a coagulase-negative Staphylococcus. CT pulmonary angiogram and transoesophageal echocardiography (TOE) were performed and revealed large vegetations adherent to the AICD leads with complete occlusion of the SVC. The infected leads were the source of sepsis. Open surgery was planned. For cardiopulmonary bypass, the venous cannula was inserted in the inferior vena cava (IVC) and a completely bloodless field was obtained in the right atrium allowing for the extraction of the AICD leads completely, along with the adherent vegetations from within. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26538129      PMCID: PMC4654209          DOI: 10.1136/bcr-2015-211772

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights.

Authors:  Andrew Voigt; Alaa Shalaby; Samir Saba
Journal:  Pacing Clin Electrophysiol       Date:  2009-09-30       Impact factor: 1.976

2.  The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia's project.

Authors:  Harry G Mond; Alessandro Proclemer
Journal:  Pacing Clin Electrophysiol       Date:  2011-06-27       Impact factor: 1.976

Review 3.  Clinical practice. Infections of cardiovascular implantable electronic devices.

Authors:  Larry M Baddour; Yong-Mei Cha; Walter R Wilson
Journal:  N Engl J Med       Date:  2012-08-30       Impact factor: 91.245

4.  Radiofrequency wire for the recanalization of central vein occlusions that have failed conventional endovascular techniques.

Authors:  Marcelo Guimaraes; Claudio Schonholz; Christopher Hannegan; Michael Bret Anderson; June Shi; Bayne Selby
Journal:  J Vasc Interv Radiol       Date:  2012-06-26       Impact factor: 3.464

5.  Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species.

Authors:  Katherine Y Le; Muhammad R Sohail; Paul A Friedman; Daniel Z Uslan; Stephen S Cha; David L Hayes; Walter R Wilson; James M Steckelberg; Larry M Baddour
Journal:  Am J Cardiol       Date:  2012-07-03       Impact factor: 2.778

6.  Bacteriology of infected extracted pacemaker and ICD leads.

Authors:  Matteo Anselmino; Melissa Vinci; Chiara Comoglio; Mauro Rinaldi; Maria Grazia Bongiorni; Gian Paolo Trevi; Pier Giorgio Golzio
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2009-09       Impact factor: 2.160

7.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Authors:  Larry M Baddour; Andrew E Epstein; Christopher C Erickson; Bradley P Knight; Matthew E Levison; Peter B Lockhart; Frederick A Masoudi; Eric J Okum; Walter R Wilson; Lee B Beerman; Ann F Bolger; N A Mark Estes; Michael Gewitz; Jane W Newburger; Eleanor B Schron; Kathryn A Taubert
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

8.  Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study.

Authors:  Daniel Z Uslan; Muhammad R Sohail; Jennifer L St Sauver; Paul A Friedman; David L Hayes; Sarah M Stoner; Walter R Wilson; James M Steckelberg; Larry M Baddour
Journal:  Arch Intern Med       Date:  2007-04-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.